ICON: A High Probability Of Success In The Uncertain R&D Process

ICON (NASDAQ: ICLR ) is the world’s second-largest Clinical Research Organization (CRO). It performs outsourced drug development activities on behalf of pharmaceutical and biotechnology companies. In simple words, it performs all functions required to set up and successfully carry out clinical trials suchLong-term investor focusing on quality companies.Coverage of US and European companies. The idea is to develop very comprehensive research reports that will be usefull when reviewing the investment case som ...